Although none of the tested cytokines could induce a detectable effect on the expression of CXCL13 and CCL21, these findings strongly suggest that the inflammatory environment in AAA tissues is able to drive the phenotypic changes of VSMCs towards chemokine-expressing LTo-like cells. The gene discussed is CCL21; the disease is triple-A syndrome.